Syra Health Corp. Class A... (SYRA)
Syra Health Class A Common Stock Statistics
Share Statistics
Syra Health Class A Common Stock has 11.91M shares outstanding. The number of shares has increased by 52.72% in one year.
| Shares Outstanding | 11.91M |
| Shares Change (YoY) | 52.72% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 10.3M |
| Failed to Deliver (FTD) Shares | 112 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 946.65K, so 9.65% of the outstanding shares have been sold short.
| Short Interest | 946.65K |
| Short % of Shares Out | 9.65% |
| Short % of Float | 11.63% |
| Short Ratio (days to cover) | 0.2 |
Valuation Ratios
The PE ratio is -0.8 and the forward PE ratio is -1.45. Syra Health Class A Common Stock's PEG ratio is 0.06.
| PE Ratio | -0.8 |
| Forward PE | -1.45 |
| PS Ratio | 0.37 |
| Forward PS | 0.5 |
| PB Ratio | 1.04 |
| P/FCF Ratio | -1.02 |
| PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Syra Health Corp. Class A Common Stock.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.16.
| Current Ratio | 5.46 |
| Quick Ratio | 5.46 |
| Debt / Equity | 0.16 |
| Total Debt / Capitalization | 13.57 |
| Cash Flow / Debt | -6.49 |
| Interest Coverage | -241.34 |
Financial Efficiency
Return on equity (ROE) is -1.31% and return on capital (ROIC) is -113.04%.
| Return on Equity (ROE) | -1.31% |
| Return on Assets (ROA) | -1.02% |
| Return on Capital (ROIC) | -113.04% |
| Revenue Per Employee | $140,036.53 |
| Profits Per Employee | $-65,951.54 |
| Employee Count | 57 |
| Asset Turnover | 2.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -77.54% in the last 52 weeks. The beta is 4.16, so Syra Health Class A Common Stock's price volatility has been higher than the market average.
| Beta | 4.16 |
| 52-Week Price Change | -77.54% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 33.98 |
| Average Volume (20 Days) | 2.31M |
Income Statement
In the last 12 months, Syra Health Class A Common Stock had revenue of 7.98M and earned -3.76M in profits. Earnings per share was -0.52.
| Revenue | 7.98M |
| Gross Profit | 1.65M |
| Operating Income | -3.76M |
| Net Income | -3.76M |
| EBITDA | -3.68M |
| EBIT | -3.76M |
| Earnings Per Share (EPS) | -0.52 |
Balance Sheet
The company has 2.4M in cash and 452.08K in debt, giving a net cash position of 1.94M.
| Cash & Cash Equivalents | 2.4M |
| Total Debt | 452.08K |
| Net Cash | 1.94M |
| Retained Earnings | -8.82M |
| Total Assets | 3.68M |
| Working Capital | 2.74M |
Cash Flow
In the last 12 months, operating cash flow was -2.93M and capital expenditures -11.11K, giving a free cash flow of -2.94M.
| Operating Cash Flow | -2.93M |
| Capital Expenditures | -11.11K |
| Free Cash Flow | -2.94M |
| FCF Per Share | -0.41 |
Margins
Gross margin is 20.71%, with operating and profit margins of -47.17% and -47.1%.
| Gross Margin | 20.71% |
| Operating Margin | -47.17% |
| Pretax Margin | -47.1% |
| Profit Margin | -47.1% |
| EBITDA Margin | -46.11% |
| EBIT Margin | -47.17% |
| FCF Margin | -36.87% |
Dividends & Yields
SYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -167.74% |
| FCF Yield | -80.37% |
Analyst Forecast
Currently there are no analyst rating for SYRA.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -0.86 |
| Piotroski F-Score | 3 |